Format

Send to

Choose Destination
See comment in PubMed Commons below
Pharmacogenomics. 2012 Sep;13(12):1351-61. doi: 10.2217/pgs.12.116.

Effects of mitotane on gene expression in the adrenocortical cell line NCI-H295R: a microarray study.

Author information

1
2nd Department of Medicine, Faculty of Medicine, Semmelweis University, Szentkirályi street 46, H-1088 Budapest, Hungary.

Abstract

AIM:

The adrenolytic agent mitotane is widely used in the treatment of adrenocortical cancer; however, its mechanism of action is poorly elucidated. We have studied mitotane-induced mRNA expression changes in the NCI-H295R adrenocortical cancer cell line.

MATERIALS & METHODS:

Cell viability and hormone assays were used to select the optimal mitotane concentration effectively inhibiting hormone secretion without affecting cell viability. RNA isolated from cultures treated for 48 and 72 h was subjected to Agilent 4×44K microarray platforms. Microarray results were validated by quantitative reverse-transcription PCR.

RESULTS:

Altogether, 117 significantly differentially expressed genes were detected at 48 h and 72 h (p < 0.05) in mitotane-treated samples relative to controls. Three significantly underexpressed genes involved in steroid hormone biosynthesis (HSD3B1, HSD3B2 and CYP21A2) and four significantly overexpressed genes (GDF15, ALDH1L2, TRIB3 and SERPINE2) have been validated.

CONCLUSION:

Gene-expression changes might be involved in the adrenal action of mitotane and in the inhibition of hormone secretion.

PMID:
22966885
DOI:
10.2217/pgs.12.116
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center